NGM BIOPHARMACEUTICALS INC Stock-Based Compensation
NGM BIOPHARMACEUTICALS INC reported Stock-Based Compensation of $28.72 million for the 12-month period ending 2023-12-31, per its 10-K filed 2024-03-11.
Discontinued › Cash Flow › Operating Activities
us-gaap:ShareBasedCompensation · last filed 2024-03-11
- NGM BIOPHARMACEUTICALS INC share-based payment arrangement, noncash expense for the quarter ending 2023-12-31 was $6.30M, a 28.23% decline year-over-year.
- NGM BIOPHARMACEUTICALS INC share-based payment arrangement, noncash expense for the quarter ending 2023-09-30 was $6.41M, a 16.63% decline year-over-year.
- NGM BIOPHARMACEUTICALS INC share-based payment arrangement, noncash expense for the quarter ending 2023-06-30 was $7.48M, a 7.73% decline year-over-year.
- NGM BIOPHARMACEUTICALS INC share-based payment arrangement, noncash expense for the quarter ending 2023-03-31 was $8.54M, a 9.17% increase year-over-year.
- NGM BIOPHARMACEUTICALS INC share-based payment arrangement, noncash expense for fiscal 2023 was $28.72M, a 11.31% decline from fiscal 2022.
- NGM BIOPHARMACEUTICALS INC share-based payment arrangement, noncash expense for fiscal 2022 was $32.38M, a 23.40% increase from fiscal 2021.
- NGM BIOPHARMACEUTICALS INC share-based payment arrangement, noncash expense for fiscal 2021 was $26.24M, a 67.67% increase from fiscal 2020.
- NGM BIOPHARMACEUTICALS INC share-based payment arrangement, noncash expense for fiscal 2020 was $15.65M, a 21.68% increase from fiscal 2019.
| Period end | Share-based Payment Arrangement, Noncash Expense 3 month | Share-based Payment Arrangement, Noncash Expense 6 month | Share-based Payment Arrangement, Noncash Expense 6 month as first filed | Share-based Payment Arrangement, Noncash Expense 9 month | Share-based Payment Arrangement, Noncash Expense 9 month as first filed | Share-based Payment Arrangement, Noncash Expense 12 month | Share-based Payment Arrangement, Noncash Expense 12 month as first filed |
|---|---|---|---|---|---|---|---|
| 2023-12-31 | $6.30M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-11 | $12.71M derived: sum of 2 quarters · filed 2024-03-11 | $20.18M derived: sum of 3 quarters · filed 2024-03-11 | $28.72M 10-K · filed 2024-03-11 | |||
| 2023-09-30 | $6.41M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-02 | $13.89M derived: sum of 2 quarters · filed 2023-11-02 | $22.42M 10-Q · filed 2023-11-02 | $31.20M derived: sum of 4 quarters · filed 2024-03-11 | |||
| 2023-06-30 | $7.48M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-03 | $16.01M 10-Q · filed 2023-08-03 | $24.79M derived: sum of 3 quarters · filed 2024-03-11 | $32.47M derived: sum of 4 quarters · filed 2024-03-11 | |||
| 2023-03-31 | $8.54M 10-Q · filed 2023-05-04 | $17.31M derived: sum of 2 quarters · filed 2024-03-11 | $25.00M derived: sum of 3 quarters · filed 2024-03-11 | $33.10M derived: sum of 4 quarters · filed 2024-03-11 | |||
| 2022-12-31 | $8.77M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-11 | $16.46M derived: sum of 2 quarters · filed 2024-03-11 | $24.56M derived: sum of 3 quarters · filed 2024-03-11 | $32.38M 10-K · filed 2024-03-11 | |||
| 2022-09-30 | $7.69M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-02 | $15.79M derived: sum of 2 quarters · filed 2023-11-02 | $23.61M 10-Q · filed 2023-11-02 | $30.19M derived: sum of 4 quarters · filed 2024-03-11 | |||
| 2022-06-30 | $8.10M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-03 | $15.92M 10-Q · filed 2023-08-03 | $22.50M derived: sum of 3 quarters · filed 2024-03-11 | $28.87M derived: sum of 4 quarters · filed 2024-03-11 | |||
| 2022-03-31 | $7.82M 10-Q · filed 2023-05-04 | $14.40M derived: sum of 2 quarters · filed 2024-03-11 | $20.76M derived: sum of 3 quarters · filed 2024-03-11 | $27.48M derived: sum of 4 quarters · filed 2024-03-11 | |||
| 2021-12-31 | $6.58M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-11 | $12.94M derived: sum of 2 quarters · filed 2024-03-11 | $19.66M derived: sum of 3 quarters · filed 2024-03-11 | $26.24M 10-K · filed 2024-03-11 | |||
| 2021-09-30 | $6.37M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-03 | $13.08M derived: sum of 2 quarters · filed 2022-11-03 | $19.66M 10-Q · filed 2022-11-03 | $23.85M derived: sum of 4 quarters · filed 2023-02-28 | |||
| 2021-06-30 | $6.72M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-04 | $13.30M 10-Q · filed 2022-08-04 | $17.48M derived: sum of 3 quarters · filed 2023-02-28 | $21.53M derived: sum of 4 quarters · filed 2023-02-28 | |||
| 2021-03-31 | $6.58M 10-Q · filed 2022-05-05 | $10.77M derived: sum of 2 quarters · filed 2023-02-28 | $14.81M derived: sum of 3 quarters · filed 2023-02-28 | $18.54M derived: sum of 4 quarters · filed 2023-02-28 | |||
| 2020-12-31 | $4.18M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-28 | $8.23M derived: sum of 2 quarters · filed 2023-02-28 | $11.96M derived: sum of 3 quarters · filed 2023-02-28 | $15.65M 10-K · filed 2023-02-28 | |||
| 2020-09-30 | $4.05M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-04 | $7.77M derived: sum of 2 quarters · filed 2021-11-04 | $11.47M 10-Q · filed 2021-11-04 | $15.08M derived: sum of 4 quarters · filed 2022-03-01 | |||
| 2020-06-30 | $3.72M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-05 | $7.42M 10-Q · filed 2021-08-05 | $11.03M derived: sum of 3 quarters · filed 2022-03-01 | $14.12M derived: sum of 4 quarters · filed 2022-03-01 | |||
| 2020-03-31 | $3.69M 10-Q · filed 2021-05-06 | $7.31M derived: sum of 2 quarters · filed 2022-03-01 | $10.40M derived: sum of 3 quarters · filed 2022-03-01 | $13.95M derived: sum of 4 quarters · filed 2022-03-01 | |||
| 2019-12-31 | $3.62M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01 | $6.71M derived: sum of 2 quarters · filed 2022-03-01 | $10.26M derived: sum of 3 quarters · filed 2022-03-01 | $12.86M 10-K · filed 2022-03-01 | $12.98M 10-K · filed 2020-03-17 | ||
| 2019-09-30 | $3.09M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-12 | $6.64M derived: sum of 2 quarters · filed 2020-11-12 | $9.25M 10-Q · filed 2020-11-12 | $9.36M 10-Q · filed 2019-11-12 | $11.66M derived: sum of 4 quarters · filed 2021-03-15 | ||
| 2019-06-30 | $3.55M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-12 | $6.16M 10-Q · filed 2020-08-12 | $6.28M 10-Q · filed 2019-08-12 | $8.57M derived: sum of 3 quarters · filed 2021-03-15 | $11.54M derived: sum of 4 quarters · filed 2021-03-15 | ||
| 2019-03-31 | $2.60M 10-Q · filed 2020-05-13 | $5.01M derived: sum of 2 quarters · filed 2021-03-15 | $7.99M derived: sum of 3 quarters · filed 2021-03-15 | $10.20M derived: sum of 4 quarters · filed 2021-03-15 | |||
| 2018-12-31 | $2.41M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-15 | $5.38M derived: sum of 2 quarters · filed 2021-03-15 | $7.59M derived: sum of 3 quarters · filed 2021-03-15 | $9.86M 10-K · filed 2021-03-15 | $9.96M 10-K · filed 2020-03-17 | ||
| 2018-09-30 | $2.97M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-12 | $5.18M derived: sum of 2 quarters · filed 2019-11-12 | $7.45M 10-Q · filed 2019-11-12 | ||||
| 2018-06-30 | $2.21M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-12 | $4.48M 10-Q · filed 2019-08-12 | |||||
| 2018-03-31 | $2.27M 10-Q · filed 2019-05-16 | ||||||
| 2017-12-31 | $7.72M 10-K · filed 2020-03-17 |